Sun Pharma's alopecia drug Deuruxolitinib gets US FDA nod

Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles, resulting in partial or complete loss of hair on the scalp and body

Related Keywords

United States ,American ,America ,Abhay Gandhi ,Adani Wilmar ,Sun Pharma ,Nicole Friedland ,Drug Administration ,Venereology Congress ,American Academy Of Dermatology ,Ezerx Health ,European Academy Of Dermatology ,National Alopecia Areata Foundation ,Sun Pharmaceutical Industries Ltd ,Pharmaceutical Industries Ltd ,America Business ,European Academy ,Som Distilleries ,Chief Executive Officer ,Alopecia ,S Fda ,Deuruxolitinib ,